Global Oncology Young Investigator Award


The Global Oncology Young Investigator Award (YIA) provides research funding to early-career investigators to encourage and promote quality research in global oncology and to develop the next generation researchers to address global health needs. Global oncology refers to the application of the concepts of global health to cancer, and implies an approach to the practice of oncology that acknowledges the reality of limited resources in most parts of the world.  

The Global Oncology Young Investigator Award is intended to support:

  1. Research by investigators in low resource settings on scientific questions specific to those settings. This research has potential to offer “reverse innovation” insights that could influence practice in a wide range of practice settings.
  2. Research by investigators in high resource settings on issues in resource-limited settings. 
  3. Collaborative research (high and low resource investigators) on questions of shared concern, such as studying a cancer type that affects a small population in the U.S. but is common in another country.

Applicants are encouraged to be innovative in their research proposal. Proposed research projects could include, but are not limited to:

  • Clinical and translational research
  • Innovative care delivery
  • Prevention and palliative care
  • Implementation research
  • Health Systems, Outcomes and Economics research related to cancer control and care


Applicants must meet the following criteria to qualify for the Global Oncology Young Investigator Award:

  • Must have received a doctoral degree (including MD, PhD, MD/PhD, DO, or equivalent doctoral degrees).
  • Must apply within the last year of training or during the first two years of faculty/staff appointment or employment at the time of grant submission.
  • Not required to have oncology-specific training but should demonstrate an interest in oncology or a related branch of science and be working in an oncology setting.
  • Be an ASCO member or have submitted a membership application with the grant application. To apply for new membership, or to renew an existing membership, go to
  • Must have and be able to show proof of appropriate institutional commitment from their institution/organization/employer which includes protected time and the provision of adequate staff, facilities, and resources to the project. The applicant institution/organization/employer must have been operating for at least one full year and have an acceptable management structure and processes in place.
  • Applications may be submitted by the following entities from the U.S. and non-U.S.:
    • Higher Education Institutions
    • Research Organizations
    • Medical and Health-related Organizations
    • Government Organizations (may include medical centers and hospitals that have access to resources and infrastructure to support a research project)
    • Nonprofit Organizations (includes medical societies or associations, advocacy organizations, foundations, hospitals)
    • Non-Governmental Organizations
  • Eligible applicants are allowed to hold only one grant from Conquer Cancer at a time.

Application Instructions

All applications must be submitted in accordance to the requirements and instructions of the Global Oncology YIA Request for Proposals (RFP). All application materials must be in English and must be submitted through the Grants Portal. Paper applications or applications sent by e-mail or fax will not be accepted.



The Global Oncology Young Investigator Award was first awarded in 2018. As of 2019, Conquer Cancer has awarded 13 early-career investigators across the globe totaling more than $600,000. 

2018 Global Oncology Young Investigator Award Recipients

Reham Abdelwahab Hassan Ali, MD, PhD
The University of Texas M.D. Anderson Cancer Center
Geonomic and Immunologic Profiling in Asian versus Western Extrahepatic Cholangiocarcinoma Patients
Edward Briercheck, MD, PhD
Dana-Farber Cancer Institute
Novel Diagnostics for Lymphoma in Guatemala
Manoj Menon, MD, MPH
Fred Hutchinson Cancer Research Center
Assessing the clinical utility of an automated molecular diagnostic test (GeneXpert Breast Cancer STRAT4 assay) in the diagnosis and management of women with breast cancer in Uganda
Clement Dove Okello, MBBS, MD
Uganda Cancer Institute, Uganda
Effects of withholding antiretroviral therapy during chemotherapy cycles in patients with HIV associated lymphomas. A pragmatic pilot study
Matthew Painschab, MD
University of North Carolina, Chapel Hill
Etiology and outcomes of neutropenic fever in patients undergoing chemotherapy for hematologic malignancies in Malawi
Monica Magdalena Rivera Franco, MD, MSc
Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran, Mexico
Feasibility of multicenter bone marrow transplantation data collection using a user-friendly online platform in a developing country
Luis Leonardo Rojas Puentes, MD
Foundation for Clinical and Applied Cancer Research, Colombia
HPV infection and immune response in metastatic lung adenocarcinoma patients


The 2018 Global Oncology Young Investigator Award is supported by:

This list reflects commitments as of July 15, 2018.


This grant receives support that may result in a report to the CMS Open Payments website under the Physician Payments Sunshine Act. The supporting companies are required to report the amount of the grant, the names of physicians who are awarded this grant, and the names of their institutions. This information may appear on the Open Payments websiteFind out more information about the Sunshine Act and CMS Open Payments program.